Qiuling Ma

633 total citations
25 papers, 338 citations indexed

About

Qiuling Ma is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Qiuling Ma has authored 25 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Qiuling Ma's work include Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (4 papers) and Electrochemical Analysis and Applications (4 papers). Qiuling Ma is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (4 papers) and Electrochemical Analysis and Applications (4 papers). Qiuling Ma collaborates with scholars based in China, Botswana and United States. Qiuling Ma's co-authors include Jie Jin, Jinghan Wang, Qitian Mu, Jiansong Huang, Yungui Wang, Mengxia Yu, Min Yang, Cheng Zhi, Sai‐Juan Chen and Shasha Lu and has published in prestigious journals such as Blood, Water Research and Applied Catalysis B: Environmental.

In The Last Decade

Qiuling Ma

23 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiuling Ma China 12 180 104 86 70 50 25 338
Mahdi Edalati Iran 12 181 1.0× 65 0.6× 54 0.6× 127 1.8× 41 0.8× 17 427
Cydney Nichols United States 7 186 1.0× 226 2.2× 175 2.0× 48 0.7× 27 0.5× 16 495
Emanuela Stampone Italy 12 168 0.9× 103 1.0× 25 0.3× 56 0.8× 34 0.7× 22 325
Michelle Maurin United States 8 340 1.9× 146 1.4× 25 0.3× 53 0.8× 23 0.5× 13 594
Gabriella Bianchino Italy 12 220 1.2× 111 1.1× 87 1.0× 76 1.1× 25 0.5× 24 429
Huo Tan China 13 216 1.2× 115 1.1× 88 1.0× 131 1.9× 43 0.9× 43 472
Yi Su China 12 194 1.1× 189 1.8× 116 1.3× 32 0.5× 51 1.0× 29 462
Sandra Parenti Italy 14 228 1.3× 75 0.7× 41 0.5× 67 1.0× 38 0.8× 27 430
Abraham Zepeda‐Moreno Mexico 11 85 0.5× 80 0.8× 96 1.1× 25 0.4× 57 1.1× 16 327
Xiaobao Xie China 11 247 1.4× 24 0.2× 97 1.1× 172 2.5× 22 0.4× 32 417

Countries citing papers authored by Qiuling Ma

Since Specialization
Citations

This map shows the geographic impact of Qiuling Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuling Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuling Ma more than expected).

Fields of papers citing papers by Qiuling Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuling Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuling Ma. The network helps show where Qiuling Ma may publish in the future.

Co-authorship network of co-authors of Qiuling Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuling Ma. A scholar is included among the top collaborators of Qiuling Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuling Ma. Qiuling Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soomro, Razium Ali, et al.. (2025). Catalytic degradation of organic pollutants in aqueous systems: A comprehensive review of peroxyacetic acid-based advanced oxidation processes. Journal of Environmental Management. 373. 123989–123989. 15 indexed citations
2.
Soomro, Razium Ali, et al.. (2025). Variable-valence Co-activated peroxyacetic acid induced rapid sulfadiazine degradation and mineralization: Co2+/Co3+ redox cycling. Chemical Engineering Journal. 523. 168329–168329. 1 indexed citations
3.
Ning, Zhiyuan, Xian Yi Tan, Wei Qian, et al.. (2025). Rapid charge transfer and non-radical pathways induced by nanoconfined Fe species/S(IV) system realized complete sulfadiazine degradation. Applied Catalysis B: Environmental. 380. 125761–125761. 3 indexed citations
4.
Ma, Qiuling, Yi‐Long Wu, Yu Zhang, et al.. (2025). A bi-specific CAR-T cell therapy targeting CD19 and CD22 in relapsed or refractory B-ALL. Clinical and Experimental Medicine. 25(1). 264–264. 1 indexed citations
5.
Zhang, Xiaofang, Zhiyuan Ning, Wei Qian, et al.. (2025). Efficient decomposition and mineralization of sulfadiazine by freezing/periodate via non-radical pathways decreased iodinated disinfection byproduct formation. Separation and Purification Technology. 377. 134454–134454.
6.
Liu, Yue, Zhiyuan Ning, Xiaofang Zhang, et al.. (2025). Rapid charge transfer and O3 selective catalysis induced by B-doped nanoconfined reactor realized complete Cu-EDTA decomplexation: Significant role of BC3 conformation. Water Research. 278. 123393–123393. 1 indexed citations
8.
Wang, Jinghan, Wenle Ye, Xiao‐Jie Yan, et al.. (2019). Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia. Journal of Translational Medicine. 17(1). 149–149. 32 indexed citations
9.
Zhi, Cheng, Qiuling Ma, Lin Shi, et al.. (2018). In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia. Molecular Therapy. 26(4). 976–985. 62 indexed citations
10.
Ma, Qiuling, Jinghan Wang, Min Yang, Huanping Wang, & Jie Jin. (2018). MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia. Journal of Translational Medicine. 16(1). 68–68. 18 indexed citations
11.
Wang, Jinghan, Mengxia Yu, Qiuling Ma, et al.. (2017). Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia. Scientific Reports. 7(1). 45960–45960. 14 indexed citations
12.
Yu, Mengxia, Jinghan Wang, Chao Hu, et al.. (2016). Prognostic impact of MYH9 expression on patients with acute myeloid leukemia. Oncotarget. 8(1). 156–163. 17 indexed citations
13.
Mu, Qitian, Qiuling Ma, Shasha Lu, et al.. (2014). 10058-F4, a c-Myc inhibitor, markedly increases valproic acid-induced cell death in Jurkat and CCRF-CEM T-lymphoblastic leukemia cells. Oncology Letters. 8(3). 1355–1359. 11 indexed citations
14.
15.
Yang, Min, Jian Huang, Qiuling Ma, Gaixiang Xu, & Jie Jin. (2014). Antitumor activity of CDA-II, a urinary preparation, on human multiple myeloma cell lines via the mitochondrial pathway. Molecular Medicine Reports. 9(3). 1025–1031. 2 indexed citations
16.
Ma, Qiuling, Jinghan Wang, Yun‐Gui Wang, et al.. (2014). High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia. International Journal of Cancer. 137(5). 1058–1065. 36 indexed citations
17.
Mu, Qitian, Yungui Wang, Bing Chen, et al.. (2013). High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia. Leukemia Research. 37(8). 922–927. 29 indexed citations
19.
Mu, Qitian, Qiuling Ma, Yungui Wang, et al.. (2012). Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population. Annals of Hematology. 91(7). 1065–1072. 10 indexed citations
20.
Yang, Min, Jiakun Shen, Jian Huang, et al.. (2009). Interleukin-6-independent expression of glucocorticoid receptor is upregulated by triptolide in multiple myeloma. Leukemia & lymphoma. 50(5). 802–808. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026